BARRY BUFFMAN: Open Payments
NPI 1356480016 · QUARTZ HILL, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$946 in 29 payments from 11 companies in 2025. Trend: 2023 $1,593 · 2024 $1,076 · 2025 $946
Food & beverage: $946
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $511 |
| Novo Nordisk Inc | 9 | $181 |
| Lilly USA, LLC | 3 | $73 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Corcept Therapeutics | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Dexcom, Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $24 |
| Kowa Pharmaceuticals America, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $17 |
Products named: AIRSUPRA, BREZTRI, JARDIANCE, Ozempic, MOUNJARO, DUPIXENT, Korlym, Wegovy.
Industry payments across CA — which companies pay providers there.
